Bausch + Lomb has announced the U.S. commercial launch of Miebo, a perfluorohexyloctane ophthalmic solution designed to treat signs and symptoms of dry eye disease by directly targeting tear evaporation.
According to a company press release, more than 38 million Americans have dry eye disease, with the majority experiencing evaporative dry eye. Miebo is a single-ingredient prescription eye drop free from water, preservatives and steroids that spreads quickly and comfortably, reducing tear evaporation at the ocular surface.
“More and more Americans are suffering from dry eye disease, due